file1,
file2, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*).
Wildcard '?' to blanket only one character works too.| Historiographs |
Grand Totals: LCS 7398, GCS 21737, CR 38784 Collection span: 1977 - 2012 | |
| Word(i) List (2518) Word count: 12056, All words count: 16977 | ||
| # | Word | Recs | TLCS | TGCS |
|---|---|---|---|---|
| 1001 | DELTA | 2 | 1 | 21 |
| 1002 | DERMOPATHY | 1 | 13 | 21 |
| 1003 | FULL | 2 | 2 | 21 |
| 1004 | FUTURE | 2 | 1 | 21 |
| 1005 | GAMMA | 2 | 1 | 21 |
| 1006 | GRAFT-VERSUS-HOST-DISEASE-LIKE | 1 | 13 | 21 |
| 1007 | GRAFTING | 2 | 3 | 21 |
| 1008 | HORIZON | 1 | 14 | 21 |
| 1009 | HYBRIDISATION | 2 | 5 | 21 |
| 1010 | INTERMEDIATE-TERM | 1 | 4 | 21 |
| 1011 | INTRAGRAFT | 2 | 2 | 21 |
| 1012 | MATTERS | 1 | 12 | 21 |
| 1013 | MYELOGENOUS | 1 | 20 | 21 |
| 1014 | NON-T | 1 | 20 | 21 |
| 1015 | REMNANT | 1 | 14 | 21 |
| 1016 | REPAIR | 4 | 20 | 21 |
| 1017 | SIGNIFICANCE | 2 | 6 | 21 |
| 1018 | SUSCEPTIBILITY | 3 | 5 | 21 |
| 1019 | SUSPECTED | 1 | 1 | 21 |
| 1020 | THREE-LOCI | 1 | 20 | 21 |
| 1021 | UNDERGO | 2 | 15 | 21 |
| 1022 | AFFECTED | 3 | 16 | 20 |
| 1023 | APPARENT | 1 | 14 | 20 |
| 1024 | ATOPY | 2 | 1 | 20 |
| 1025 | CARCINOMAS | 1 | 18 | 20 |
| 1026 | CHARACTER | 1 | 9 | 20 |
| 1027 | COMPARISON | 4 | 7 | 20 |
| 1028 | DEVELOPMENTS | 2 | 1 | 20 |
| 1029 | DIFFERENCES | 5 | 1 | 20 |
| 1030 | DIMORPHISM | 2 | 1 | 20 |
| # | Word | Recs | TLCS | TGCS |
| 1031 | DYSREGULATION | 1 | 0 | 20 |
| 1032 | EPISODES | 3 | 14 | 20 |
| 1033 | EVOLUTION | 3 | 9 | 20 |
| 1034 | EXAMPLE | 1 | 17 | 20 |
| 1035 | GENERATION | 1 | 3 | 20 |
| 1036 | GRADE | 1 | 18 | 20 |
| 1037 | GROUP | 4 | 3 | 20 |
| 1038 | HEMATOLOGICAL | 3 | 0 | 20 |
| 1039 | HEMOPOIETIC | 1 | 2 | 20 |
| 1040 | KERATINOCYTES | 1 | 17 | 20 |
| 1041 | LICHENOIDES | 1 | 17 | 20 |
| 1042 | OBSERVATIONS | 2 | 8 | 20 |
| 1043 | PITYRIASIS | 1 | 17 | 20 |
| 1044 | POSTTRANSPLANT | 3 | 4 | 20 |
| 1045 | PREGNANCIES | 3 | 12 | 20 |
| 1046 | RAT-LIMB | 1 | 3 | 20 |
| 1047 | REEXPOSURE | 1 | 0 | 20 |
| 1048 | RETROSPECTIVE | 1 | 1 | 20 |
| 1049 | SEXUAL | 2 | 1 | 20 |
| 1050 | SPITE | 1 | 14 | 20 |
| 1051 | SUBCLINICAL | 1 | 1 | 20 |
| 1052 | SUSTAINS | 2 | 9 | 20 |
| 1053 | T-CELL | 6 | 2 | 20 |
| 1054 | TYPING | 6 | 15 | 20 |
| 1055 | VESTIGE | 1 | 9 | 20 |
| 1056 | ADULTHOOD | 1 | 17 | 19 |
| 1057 | BEGINS | 1 | 14 | 19 |
| 1058 | CONCEPT | 1 | 4 | 19 |
| 1059 | CONFLICTING | 1 | 8 | 19 |
| 1060 | CULTURE | 4 | 1 | 19 |
| # | Word | Recs | TLCS | TGCS |
| 1061 | D-RECIPIENTS | 1 | 0 | 19 |
| 1062 | DETECT | 9 | 4 | 19 |
| 1063 | DIMINISH | 1 | 10 | 19 |
| 1064 | DTH | 1 | 0 | 19 |
| 1065 | END | 1 | 14 | 19 |
| 1066 | EXPERIMENTS | 1 | 8 | 19 |
| 1067 | FAILURE | 10 | 3 | 19 |
| 1068 | FOUR | 2 | 0 | 19 |
| 1069 | IDENTICAL | 2 | 3 | 19 |
| 1070 | INFANTS | 2 | 0 | 19 |
| 1071 | INVOLVED | 7 | 10 | 19 |
| 1072 | LEAD | 2 | 6 | 19 |
| 1073 | LEUKOREDUCTION | 1 | 10 | 19 |
| 1074 | OLDER | 1 | 4 | 19 |
| 1075 | PAPILLARY | 3 | 19 | 19 |
| 1076 | POPULATIONS | 3 | 10 | 19 |
| 1077 | STORY | 1 | 14 | 19 |
| 1078 | TRANS-VIVO | 1 | 0 | 19 |
| 1079 | VASCULAR | 3 | 4 | 19 |
| 1080 | VERY-LOW-BIRTHWEIGHT | 1 | 0 | 19 |
| 1081 | XENOGENEIC | 6 | 7 | 19 |
| 1082 | ZYGOSITY | 1 | 15 | 19 |
| 1083 | ABUNDANT | 1 | 2 | 18 |
| 1084 | ADOPTIVE | 1 | 0 | 18 |
| 1085 | AUTOPSY | 1 | 0 | 18 |
| 1086 | CD40 | 1 | 0 | 18 |
| 1087 | COMMUNITY-BASED | 1 | 11 | 18 |
| 1088 | CORRELATE | 3 | 5 | 18 |
| 1089 | ELIMINATION | 3 | 3 | 18 |
| 1090 | ENHANCES | 2 | 0 | 18 |
| # | Word | Recs | TLCS | TGCS |
| 1091 | EPIDEMIOLOGY | 1 | 3 | 18 |
| 1092 | FOE | 2 | 12 | 18 |
| 1093 | FRIEND | 2 | 12 | 18 |
| 1094 | IMMUNOGLOBULIN | 1 | 0 | 18 |
| 1095 | IMPLANTATION | 3 | 7 | 18 |
| 1096 | INVESTIGATION | 2 | 4 | 18 |
| 1097 | LIVER-ASSOCIATED | 1 | 2 | 18 |
| 1098 | NEPHRITIS | 3 | 12 | 18 |
| 1099 | PERFUSATE | 1 | 2 | 18 |
| 1100 | PRETERM | 2 | 2 | 18 |
| 1101 | PROTOCOLS | 1 | 6 | 18 |
| 1102 | REINFECTION | 1 | 0 | 18 |
| 1103 | SHORT | 5 | 1 | 18 |
| 1104 | SUFFERING | 2 | 0 | 18 |
| 1105 | TOLERANCE-INDUCING | 1 | 6 | 18 |
| 1106 | UMBILICAL | 3 | 0 | 18 |
| 1107 | VIRUS | 4 | 0 | 18 |
| 1108 | WOODCHUCK | 1 | 0 | 18 |
| 1109 | ALLOANTIBODIES | 1 | 0 | 17 |
| 1110 | ARGUES | 1 | 10 | 17 |
| 1111 | CD25 | 2 | 1 | 17 |
| 1112 | CD46 | 1 | 0 | 17 |
| 1113 | CD54 | 2 | 1 | 17 |
| 1114 | CLINICALLY | 2 | 15 | 17 |
| 1115 | CONTRIBUTES | 1 | 1 | 17 |
| 1116 | CORRECTS | 1 | 2 | 17 |
| 1117 | DELIVERY | 2 | 13 | 17 |
| 1118 | DIABETIC | 3 | 4 | 17 |
| 1119 | DIRECT | 2 | 8 | 17 |
| 1120 | DIRECTED | 1 | 1 | 17 |
| # | Word | Recs | TLCS | TGCS |
| 1121 | DYNAMIC | 3 | 15 | 17 |
| 1122 | ELEVEN | 1 | 0 | 17 |
| 1123 | FORMATION | 5 | 2 | 17 |
| 1124 | HUS | 1 | 0 | 17 |
| 1125 | IMMEDIATELY | 2 | 0 | 17 |
| 1126 | LEUCOCYTE | 4 | 3 | 17 |
| 1127 | LIFELONG | 1 | 11 | 17 |
| 1128 | LOW | 4 | 1 | 17 |
| 1129 | LYMPHOBLASTIC | 3 | 10 | 17 |
| 1130 | MCP | 1 | 0 | 17 |
| 1131 | MEMBRANES | 1 | 2 | 17 |
| 1132 | MILLION | 1 | 0 | 17 |
| 1133 | MINIMALLY | 1 | 1 | 17 |
| 1134 | MUTATION | 2 | 0 | 17 |
| 1135 | ONE | 3 | 0 | 17 |
| 1136 | PARENT-OF-ORIGIN | 3 | 2 | 17 |
| 1137 | PERFUSION | 1 | 0 | 17 |
| 1138 | PHYSIOLOGIC | 1 | 11 | 17 |
| 1139 | PNEUMOCYTE | 1 | 1 | 17 |
| 1140 | POOL | 1 | 1 | 17 |
| 1141 | PREREQUISITE | 2 | 5 | 17 |
| 1142 | PRIOR | 5 | 10 | 17 |
| 1143 | PROSPECTS | 1 | 3 | 17 |
| 1144 | PROTOCOL | 2 | 1 | 17 |
| 1145 | REASSESSMENT | 1 | 0 | 17 |
| 1146 | RECEIVED | 2 | 0 | 17 |
| 1147 | RECURRENCE | 1 | 0 | 17 |
| 1148 | ROLES | 2 | 11 | 17 |
| 1149 | SCID | 2 | 2 | 17 |
| 1150 | SEVEN | 1 | 15 | 17 |
| # | Word | Recs | TLCS | TGCS |
| 1151 | SUBTHERAPEUTIC | 1 | 1 | 17 |
| 1152 | TRIGGER | 1 | 10 | 17 |
| 1153 | ULCERATIVE | 2 | 14 | 17 |
| 1154 | UNAFFECTED | 2 | 15 | 17 |
| 1155 | WORLDWIDE | 1 | 0 | 17 |
| 1156 | 2-LOCI-MISMATCHED | 2 | 5 | 16 |
| 1157 | ABNORMAL | 1 | 2 | 16 |
| 1158 | AUGMENTATION | 4 | 4 | 16 |
| 1159 | CONTROL | 3 | 0 | 16 |
| 1160 | DETERMINANTS | 1 | 11 | 16 |
| 1161 | DETERMINATION | 7 | 4 | 16 |
| 1162 | EXHIBIT | 1 | 2 | 16 |
| 1163 | FLT-3 | 1 | 1 | 16 |
| 1164 | FLUOROGENIC | 1 | 2 | 16 |
| 1165 | GENETICS | 2 | 1 | 16 |
| 1166 | HUMANS | 3 | 6 | 16 |
| 1167 | IMMUNOGENETIC | 2 | 0 | 16 |
| 1168 | IMMUNOPHENOTYPING | 2 | 12 | 16 |
| 1169 | INVESTIGATIONS | 1 | 0 | 16 |
| 1170 | ITALIAN | 1 | 10 | 16 |
| 1171 | LENGTH | 3 | 4 | 16 |
| 1172 | LOCI | 4 | 12 | 16 |
| 1173 | MAINTAIN | 3 | 3 | 16 |
| 1174 | MEASURE | 1 | 2 | 16 |
| 1175 | MICROCHIMAERISM | 2 | 6 | 16 |
| 1176 | OPENMINDEDNESS | 1 | 0 | 16 |
| 1177 | PREGNANCY-ASSOCIATED | 4 | 7 | 16 |
| 1178 | T-CELL-REPLETE | 1 | 10 | 16 |
| 1179 | THERAPEUTIC | 2 | 1 | 16 |
| 1180 | TOLEROGENICITY | 1 | 2 | 16 |
| # | Word | Recs | TLCS | TGCS |
| 1181 | TRANSIENTLY | 2 | 1 | 16 |
| 1182 | WAITING | 1 | 3 | 16 |
| 1183 | ABORTION | 2 | 12 | 15 |
| 1184 | ADOLESCENTS | 2 | 4 | 15 |
| 1185 | ALLOIMMUNIZATION | 3 | 8 | 15 |
| 1186 | ANGIOGENESIS | 2 | 11 | 15 |
| 1187 | ASCERTAINMENT | 1 | 10 | 15 |
| 1188 | BIOLOGICAL | 2 | 10 | 15 |
| 1189 | CHARACTERIZATION | 3 | 1 | 15 |
| 1190 | CULTURES | 2 | 2 | 15 |
| 1191 | DAMAGE | 2 | 14 | 15 |
| 1192 | DEATH | 1 | 10 | 15 |
| 1193 | DECEASED | 2 | 4 | 15 |
| 1194 | DIFFERENTIATED | 1 | 14 | 15 |
| 1195 | DIMINISHED | 3 | 11 | 15 |
| 1196 | DIVERSE | 1 | 14 | 15 |
| 1197 | DR-MATCHED | 1 | 12 | 15 |
| 1198 | FLOW | 5 | 6 | 15 |
| 1199 | HLA-A | 1 | 12 | 15 |
| 1200 | IMAGING | 2 | 11 | 15 |